Search results
David A. Braun, MD, PhD Principal Investigator. David is a physician-scientist, an Assistant Professor at the Yale School of Medicine, a Goodman and Gilman Yale Scholar, and a principal investigator in the Center of Molecular and Cellular Oncology within the Yale Cancer Center.
Feb 15, 2024 · Dr David Braun reflects on how a question from a patient changed the way in which he viewed considerations in evolving RCC treatments.
May 7, 2024 · Urology Times staff. “What we need is continued work on integrating surgery and systemic therapy,” says Patrick Kenney, MD. In this interview, David Braun, MD, PhD, and Patrick Kenney, MD, describe their practices and touch on unmet needs in kidney cancer treatment.
David Braun, MD, PhD, is an Assistant Professor of Medicine (Medical Oncology) and a member of the Center of Molecular and Cellular Oncology (CMCO) at Yale Cancer Center. Dr. Dr. Braun cares for patients with kidney cancers.
David A. Braun, MD, PhD, discusses the enrichment of SLAMF7-positive, CD8-positive T-cells and their role on nivolumab resistance in clear cell and non–clear cell renal cell carcinoma.
Feb 21, 2023 · David Braun, MD, PhD, Assistant Professor of Medicine (Medical Oncology) and the Louis Goodman and Alfred Gilman Yale Scholar, has been awarded a American Society for Clinical Investigation (ASCI) Young Physician-Scientist Award.
Oct 5, 2024 · David Braun, MD, PhD, is an assistant professor of medicine and a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center.
